The abstract is read at the publisher; the summary is JClub's.
Sacubitril/valsartan prophylaxis is linked to improved left ventricular global longitudinal strain and aortic compliance in paediatric post-radiotherapy patients, with a favourable safety profile.
- Why it matters: Radiation-induced heart disease is a life-threatening late effect in young cancer survivors, and preventive evidence in children is scarce.
- What they did: In a prospective clinical cohort of 15 sacubitril/valsartan and 15 control patients, investigators followed outcomes for 12 months after radiotherapy, assessing efficacy and safety.
- The result: Sacubitril/valsartan significantly improved left ventricular global longitudinal strain and aortic compliance versus controls, while showing a favourable safety profile.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.